Friday, December 22, 2017
Gold prospecting in Philippines - TreasureNet www.treasurenet.com › Forum › Gold Prospecting Forum › Gold Prospecting Oct 16, 2010 - Re: Gold prospecting in Philippines. (Finding gold) Go to this site http://www.mindat.org/loc-21930.html >find your region on the map or find your prvovince in the list below>open all the links and find the ones that say major commodities gold or trace gold. (my opinion) Perhaps after seeing all the sites find ...
Tuesday, December 12, 2017
How we use cookies Cookies do not contain any information that personally identifies you, but personal information that we store about you may be linked, by us, to the information stored in and obtained from cookies. The cookies used on the website include those which are strictly necessary cookies for access and navigation, cookies that track usage (performance cookies), remember your choices (functionality cookies), and cookies that provide you with targeted content or advertising. We may use the information we obtain from your use of our cookies for the following purposes: to recognise your computer when you visit the website to track you as you navigate the website, and to enable the use of any e-commerce facilities to improve the website's usability to analyse the use of the website in the administration of the website to personalise the website for you, including targeting advertisements which may be of particular interest to you. Third party cookies When you use the website, you may also be sent third party cookies. Our advertisers and service providers may send you cookies. They may use the information they obtain from your use of their cookies: to track your browser across multiple websites to build a profile of your web surfing to target advertisements which may be of particular interest to you. In addition to the information we provide in this Cookie Policy, you can find out more information about your online choices at http://www.youronlinechoices.com/uk/opt-out-help Blocking cookies Most browsers allow you to refuse to accept cookies. For example: in Internet Explorer you can refuse all cookies by clicking "Tools", "Internet Options", "Privacy", and selecting "Block all cookies" using the sliding selector; in Firefox you can block all cookies by clicking "Tools", "Options", and un-checking "Accept cookies from sites" in the "Privacy" box. in Google Chrome you can adjust your cookie permissions by clicking "Options", "Under the hood", Content Settings in the "Privacy" section. Click on the Cookies tab in the Content Settings. in Safari you can block cookies by clicking “Preferences”, selecting the “Privacy” tab and “Block cookies”. Blocking all cookies will, however, have a negative impact upon the usability of many websites. If you block cookies, you may not be able to use certain features on the website (log on, access content, use search functions). Deleting cookies You can also delete cookies already stored on your computer: in Internet Explorer, you must manually delete cookie files; in Firefox, you can delete cookies by, first ensuring that cookies are to be deleted when you "clear private data" (this setting can be changed by clicking "Tools", "Options" and "Settings" in the "Private Data" box) and then clicking "Clear private data" in the "Tools" menu. in Google Chrome you can adjust your cookie permissions by clicking "Options", "Under the hood", Content Settings in the "Privacy" section. Click on the Cookies tab in the Content Settings. in Safari you can delete cookies by clicking “Preferences”, selecting the “Privacy” tab and “Remove All Website Data”. Obviously, doing this may have a negative impact on the usability of many websites. Contact us The website is owned and operated by Macmillan Publishers Limited, a company registered in England under company number 00785998 with a registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom. Our VAT number is GB199440621. If you have any questions or comments about this Notice, or if you would like us to update information we have about you or your preferences, please contact us by: Calling: +44 207 843 4869 / +1 212 726 9200 Sending an email to: feedback@nature.com Writing to: Customer Services Department Nature Research The Campus 4 Crinan Street London N1 9SQ United Kingdom or Customer Service Department Nature Research One New York Plaza Suite 4500 New York NY 10004-1562 USA
How we use cookies Cookies do not contain any information that personally identifies you, but personal information that we store about you may be linked, by us, to the information stored in and obtained from cookies. The cookies used on the website include those which are strictly necessary cookies for access and navigation, cookies that track usage (performance cookies), remember your choices (functionality cookies), and cookies that provide you with targeted content or advertising. We may use the information we obtain from your use of our cookies for the following purposes: to recognise your computer when you visit the website to track you as you navigate the website, and to enable the use of any e-commerce facilities to improve the website's usability to analyse the use of the website in the administration of the website to personalise the website for you, including targeting advertisements which may be of particular interest to you. Third party cookies When you use the website, you may also be sent third party cookies. Our advertisers and service providers may send you cookies. They may use the information they obtain from your use of their cookies: to track your browser across multiple websites to build a profile of your web surfing to target advertisements which may be of particular interest to you. In addition to the information we provide in this Cookie Policy, you can find out more information about your online choices at http://www.youronlinechoices.com/uk/opt-out-help Blocking cookies Most browsers allow you to refuse to accept cookies. For example: in Internet Explorer you can refuse all cookies by clicking "Tools", "Internet Options", "Privacy", and selecting "Block all cookies" using the sliding selector; in Firefox you can block all cookies by clicking "Tools", "Options", and un-checking "Accept cookies from sites" in the "Privacy" box. in Google Chrome you can adjust your cookie permissions by clicking "Options", "Under the hood", Content Settings in the "Privacy" section. Click on the Cookies tab in the Content Settings. in Safari you can block cookies by clicking “Preferences”, selecting the “Privacy” tab and “Block cookies”. Blocking all cookies will, however, have a negative impact upon the usability of many websites. If you block cookies, you may not be able to use certain features on the website (log on, access content, use search functions). Deleting cookies You can also delete cookies already stored on your computer: in Internet Explorer, you must manually delete cookie files; in Firefox, you can delete cookies by, first ensuring that cookies are to be deleted when you "clear private data" (this setting can be changed by clicking "Tools", "Options" and "Settings" in the "Private Data" box) and then clicking "Clear private data" in the "Tools" menu. in Google Chrome you can adjust your cookie permissions by clicking "Options", "Under the hood", Content Settings in the "Privacy" section. Click on the Cookies tab in the Content Settings. in Safari you can delete cookies by clicking “Preferences”, selecting the “Privacy” tab and “Remove All Website Data”. Obviously, doing this may have a negative impact on the usability of many websites. Contact us The website is owned and operated by Macmillan Publishers Limited, a company registered in England under company number 00785998 with a registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom. Our VAT number is GB199440621. If you have any questions or comments about this Notice, or if you would like us to update information we have about you or your preferences, please contact us by: Calling: +44 207 843 4869 / +1 212 726 9200 Sending an email to: feedback@nature.com Writing to: Customer Services Department Nature Research The Campus 4 Crinan Street London N1 9SQ United Kingdom or Customer Service Department Nature Research One New York Plaza Suite 4500 New York NY 10004-1562 USA
Tuesday, September 12, 2017
Sunday, September 10, 2017
Magnetite pollution nanoparticles in the human brain
Current Issue > vol. 113 no. 39 > Barbara A. Maher, 10797–10801, doi: 10.1073/pnas.1605941113
Significance
We identify the abundant presence in the human brain of magnetite nanoparticles that match precisely the high-temperature magnetite nanospheres, formed by combustion and/or friction-derived heating, which are prolific in urban, airborne particulate matter (PM). Because many of the airborne magnetite pollution particles are <200 nm in diameter, they can enter the brain directly through the olfactory nerve and by crossing the damaged olfactory unit. This discovery is important because nanoscale magnetite can respond to external magnetic fields, and is toxic to the brain, being implicated in production of damaging reactive oxygen species (ROS). Because enhanced ROS production is causally linked to neurodegenerative diseases such as Alzheimer’s disease, exposure to such airborne PM-derived magnetite nanoparticles might need to be examined as a possible hazard to human health.
Next Section
Abstract
Biologically formed nanoparticles of the strongly magnetic mineral, magnetite, were first detected in the human brain over 20 y ago [Kirschvink JL, Kobayashi-Kirschvink A, Woodford BJ (1992) Proc Natl Acad Sci USA 89(16):7683–7687]. Magnetite can have potentially large impacts on the brain due to its unique combination of redox activity, surface charge, and strongly magnetic behavior. We used magnetic analyses and electron microscopy to identify the abundant presence in the brain of magnetite nanoparticles that are consistent with high-temperature formation, suggesting, therefore, an external, not internal, source. Comprising a separate nanoparticle population from the euhedral particles ascribed to endogenous sources, these brain magnetites are often found with other transition metal nanoparticles, and they display rounded crystal morphologies and fused surface textures, reflecting crystallization upon cooling from an initially heated, iron-bearing source material. Such high-temperature magnetite nanospheres are ubiquitous and abundant in airborne particulate matter pollution. They arise as combustion-derived, iron-rich particles, often associated with other transition metal particles, which condense and/or oxidize upon airborne release. Those magnetite pollutant particles which are <∼200 nm in diameter can enter the brain directly via the olfactory bulb. Their presence proves that externally sourced iron-bearing nanoparticles, rather than their soluble compounds, can be transported directly into the brain, where they may pose hazard to human health.
brain magnetite magnetite pollution particles Alzheimer's disease combustion-derived nanoparticles airborne particulate matter
Magnetic analyses of human brain samples have identified the presence of nanoparticles of magnetite, a strongly magnetic (ferrimagnetic) mixed Fe2+/Fe3+ iron oxide (1⇓–3). Based on their nanoscale dimensions and euhedral (cubo-octahedral or prismatic) crystal shapes, these magnetite nanoparticles are thought to have formed by biological processes (1, 4), via in situ crystallization, possibly within the 8-nm-diameter cores of the iron storage protein, ferritin (e.g., ref. 5).
The specific presence of magnetite in the brain is important because it has been causally linked with potential cellular responses to external magnetic fields (e.g., in magnetic resonance imaging studies) (1), aging (6), and with neurodegenerative disease (e.g., refs. 2, 3, and 7). Previous work has shown a correlation between the amount of brain magnetite and the incidence of Alzheimer’s disease (AD) (2, 3). Neuropathological changes associated with AD include the formation of senile plaques, containing Ī²-amyloid fibrils (e.g., refs. 8, and 9). When associated with redox-active transition metal ions, such as Fe2+ ions, Ī²-amyloid can generate damaging reactive oxygen species, directly contributing to oxidative brain damage, a key early feature of AD (e.g., refs. 8⇓–10). Magnetite nanoparticles have been found directly associated with AD plaques and tangles (e.g., refs. 11⇓–13). In vitro experimental data show that magnetite acts synergistically to enhance the toxicity of Ī²-amyloid (7).
We used magnetometry, high-resolution transmission electron microscopy (HRTEM), electron energy loss spectroscopy (EELS), and energy dispersive X-ray (EDX) analysis to examine the mineralogy, morphology, and composition of magnetic nanoparticles in and from the frontal cortex of 37 human brain samples, obtained from subjects who lived in Mexico City (14) (29 cases; ages 3 to 85 y; two females) and in Manchester, UK (8 cases; ages 62 to 92 y; five females; Tables S1 and S2). These brain magnetites display compelling similarity with the magnetite nanospheres formed by combustion, which are ubiquitous and prolific in urban, airborne particulate matter (PM) (15⇓⇓⇓–19). We report here identification of the presence in human brain tissue of magnetite nanoparticles with an external, rather than an endogenous, source.
In this window In a new window
Table S1.
Summary of Mexico City cases studied
In this window In a new window
Table S2.
Summary of Manchester cases studied
Previous Section
Next Section
Results
To quantify brain magnetic content, a cryogenic magnetometer was used to measure, at room and low temperature (77 K), the saturation magnetic remanence (SIRM) of frontal tissue samples, initially fresh-frozen and subsequently freeze-dried. The SIRM 77 K captures the magnetic contribution of ferrimagnetic grains that are so small (<∼20 nm) as to be magnetically unstable (superparamagnetic) at room temperature. The magnetic brain particles were then examined directly, by HRTEM and EDX analyses both of ultrathin tissue sections and of magnetically extracted particles, after tissue digestion with the proteolytic enzyme, papain. Every analytical step was designed and monitored to preclude any possible magnetic contamination.
The brain magnetic analyses identify the presence in all of the samples of strongly magnetic, easily magnetized nanoparticles, with concentrations ranging from 0.2 to 12 Āµg/g dry tissue (Fig. S1). The sample magnetic properties are dominated by behavior characteristic of interacting clusters of ferrimagnetic magnetite or maghemite (Fig. S2). Although highest brain magnetite concentrations (>10 Āµg/g dry tissue) are seen in many of the oldest cases, several of the much younger Mexico City cases, some exposed to high ambient concentrations of fine-grained (<2.5 Āµm aerodynamic diameter) airborne PM, also display high ferrimagnetic concentrations. Indeed, the highest brain magnetite content is found in a 32-y-old Mexico City resident (Fig. S1).
Fig. S1.
In a new window Download PPT
Fig. S1.
SIRM 77 K (10−6 A m2/kg) and estimated magnetite concentration (micrograms per gram) for frontal cortex samples versus age at death, Mexico City and Manchester cases. The annual mean airborne PM2.5 concentration (micrograms per cubic meter) is given for the residence area of the Mexican cases (inside each data symbol); SIRM values for gray (g) and white (w) matter are given for the Manchester cases, together with their clinical diagnosis upon death (CAA, cerebral amyloid angiopathy; CVD, cerebrovascular disease; DLB, dementia with Lewy bodies; see Tables S1 and S2).
Fig. S2.
In a new window Download PPT
Fig. S2.
Magnetic analyses of brain tissue samples (freeze-dried): (A) acquisition of isothermal (RT) remanent magnetization in applied DC fields from 5 mT to 1 T. All samples acquire most of their magnetization at fields < 100 mT, indicating the dominant presence of ferrimagnetic minerals (e.g., magnetite and/or maghemite). The magnetically softest sample (the Mexico City case to the left of all remaining samples) has the highest SIRM value (case 282). (B) Measurement of LT remanence (77 K, DC field 1 T) upon warming to RT, showing the thermal unblocking of the superparamagnetic particles. (C) Comparison between the brain samples and sized, synthetic magnetites of known grain size and degree of dispersion (37), as measured by the RT ARM, normalized by the SIRM, plotted against the median destructive field of the ARM (MDFARM, in milliteslas). All of the measurable brain samples fall within the region of the least-dispersed synthetic, submicrometer magnetites, indicating magnetic interactions, and hence agglomeration/clustering of some of the brain magnetite particles.
HRTEM and EELS analyses of the tissue sections identify the presence within frontal cells of magnetite, occurring as two distinct types of nanoparticle (Fig. 1 and Figs. S3 and S4). The majority of particles display rounded, even spherical morphologies (Fig. 1A, with higher magnification in Fig. 1B, and Fig. 1F), with diameters between 10 and 150 nm (Fig. S5). The additional presence in the brain cells of other transition metal nanoparticles, containing Pt, Ni, and Co (and possibly Cu), is identified by EELS (Fig. S6) and EDX (Figs. S7 and S8). These rounded magnetites contrast strongly with the angular, cubo-octahedral magnetite crystals also observed (relatively very rarely) within the brain tissue samples (Fig. 1C, and with higher magnification in Fig. 1D).
Fig. 1.
In a new window Download PPT
Fig. 1.
Transmission electron micrographs of brain thin sections, identifying two distinct types of magnetite morphologies within frontal cells: (A and F) rounded particles (A shown at higher magnification in B); and (C) angular, euhedral particles, which we attribute to endogenous formation (particles from C shown at higher magnification in D). (E) EELS spectra (in blue) for the rounded particle shown in F and for standard iron oxide species. The position of the Fe−L3 edge absorption peak, the broad feature of the Fe−L2 (compared with the sharp edges, arrowed, of the fully oxidized Fe3+ phases), and the integrated areas of the L3/L2 (5.5) and the Fe/O (0.56) are all consistent with magnetite (also see Figs. S3 and S4).
Fig. S3.
In a new window Download PPT
Fig. S3.
(A) High-angle annular diffraction and (B) dark-field TEM micrographs showing spherical magnetic nanoparticles in brain tissues. (C) Fe−L2,3 EELS spectra of nanoparticles identified in the selected areas (boxes 1 through 4) showing the absence of any preedges (see hematite, goethite, and ferrihydrite preedge at ∼708.8 eV), Fe−L3 edges centered at 708 eV, and broad Fe−L2 features characteristic of magnetite, compared with the Fe−L2,3 EELS spectra (D) of standard magnetite, siderite, hematite, goethite, and two-line ferrihydrite.
Fig. S4.
In a new window Download PPT
Fig. S4.
Fe−L2,3-edge spectra of magnetic particles found in brain samples. The Fe−L3 and Fe−L2 edges in all three samples are at 708.7 to 709.8 eV and 72 to 723 eV, in excellent agreement with the chemical shift in EELS spectra for the magnetite structure (also see Fig. S3).
Fig. S5.
In a new window Download PPT
Fig. S5.
Particle size distribution of magnetic particles in brain magnetic extracts. Particle size measurements were carried out on all of the HRTEM micrographs collected from six brain magnetic extracts from different subjects. The ImageJ software package was used to describe the imaged particles (spherical and nonspherical) in terms of the longest and shortest diameters, perimeter projected area, or equivalent spherical diameter.
Fig. S6.
In a new window Download PPT
Fig. S6.
(A) Co−L2,3 EELS spectra of cobalt (II, III) oxide nanoparticles associated with magnetite particles in brain tissues. Co−L3 and Co−L2 edges from different areas of a brain tissue sample (B) are centered at ∼780 and ∼796 eV, respectively, in a good match with an EELS spectrum of a standard cobalt (II,III) oxide.
Fig. S7.
In a new window Download PPT
Fig. S7.
EDX analysis of metal-bearing NPs in brain tissue samples, showing presence of Fe, Ni, and Co (and possibly Cu, with the caveat that the samples were mounted on holey carbon films on Cu grids).
Fig. S8.
In a new window Download PPT
Fig. S8.
EDX analysis of metal-bearing NPs in brain tissue samples, showing the presence of Fe, Ni, Pt, Co, and, possibly, Cu.
Crystallographic analysis of the particles within the tissue sections is difficult (due to rapid carbon buildup under the microscope electron beam). We therefore examined magnetically extracted (20) brain particles, to more fully characterize their mineralogy, surface textures, and particle size distribution. In accord with the observations on the untreated tissue samples, many of the extracted particles display rounded to spherical morphologies (Fig. 2 and Figs. S7–S10). In particular, some have fused surface crystallites (Fig. 2H) that would be very difficult to reconcile with low-temperature growth or dissolution formation processes. Indexing of the lattice fringes of the HRTEM of these particles is consistent with the magnetite crystal structure (Fig. 2 C, E, and G). Some surface oxidation toward its oxidized counterpart, maghemite, is evident (Fig. 2I). The particle size distribution of the rounded brain magnetite particles is notably broad, with a median (longest) diameter of 18 nm and maximum diameter of ∼150 nm (Fig. S5). Such dimensions greatly exceed those of nanoparticles formed within the 8-nm diameter of ferritin cores (5).
Fig. 2.
In a new window Download PPT
Fig. 2.
Transmission electron micrographs of rounded particles magnetically extracted from human brain samples: (A, D, F, and H) Mexico City cases; (B) Manchester case. (H) A large (∼150-nm diameter) spherical particle with fused, interlocking magnetite/maghemite surface crystallites. (C, E, and G) Indexing of the lattice fringes of the brain particles is consistent with the (400) reflection of magnetite and (I) mixed magnetite and maghemite of selected areas 1–5 in H.
Fig. S9.
In a new window Download PPT
Fig. S9.
(A–I) A collection of HRTEM micrographs of magnetite particles, extracted from brain tissues, showing dominant rounded morphologies. (C) Micrograph shows fused magnetite particles, and (D and E) micrographs show aggregated magnetite particles.
Fig. S10.
In a new window Download PPT
Fig. S10.
(A) HRTEM micrograph of magnetically extracted magnetite particles from brain tissues. (B−D) FFT patterns of selected areas (1, 2, and 3, respectively) featuring a single crystal (B) and magnetite particles superimposed at ∼90° (C and D).
Previous Section
Next Section
Discussion
The geometric, angular particles resemble the in situ, biogenic magnetite previously reported (1, 4); we thus ascribe these euhedral magnetite particles to endogenous formation. The rounded magnetite nanoparticles (up to ∼150-nm diameter, with distinctive surface textures, and cooccurring with other PM-associated metals, including Pt) have not been identified previously in brain tissue sections. Apparently similar spherical structures, with diameters of 8 to 50 nm, have been found recently within amyloid plaque cores isolated from human brain (13) but were attributed to a biological rather than an external pollution-derived source. However, the surface textures, size, and size distribution of the spherical magnetites identified in our study, and the cooccurrence of PM-associated transition metal nanoparticles, are all inconsistent with the characteristics of biogenically formed magnetite (1, 4, 12). They bear compelling resemblance, instead, to the rounded/spherical magnetite nanoparticles (nanospheres) that are both ubiquitous and prolific within airborne, high-temperature (combustion-derived) PM (15⇓⇓⇓–19, 21). The rounded shapes of these airborne, PM-derived magnetites (Fig. 3 and Fig. S11), and fusing of interlocking, surface crystallites (Fig. 3 C and D), reflect their high-temperature sources, and their subsequent crystallization, upon rapid cooling and/or oxidation, as Fe-rich nanospheres. Depending on PM source(s) (vehicular, subway, industrial, indoor), other transition metals are often coassociated with magnetite and other pollution nanoparticles (15⇓–17, 19). Pt release, for instance, is associated with increasing vehicular use of catalytic converters (e.g., ref. 22). Frictional heating, e.g., of brake pads, can also produce high-temperature magnetite nanoparticles (21). Magnetite can arise from combustion of many types of organic matter, depending on heating temperature and atmosphere, and source Fe content (23⇓–25).
Fig. 3.
In a new window Download PPT
Fig. 3.
TEM/scanning EM micrographs of anthropogenic (combustion-derived), magnetically extracted airborne particles. (A, shown at higher magnification in B) Magnetite nanoparticles from airborne PM (<10 Āµm), from Cable Street, Lancaster, United Kingdom (March 2009), sampled with a cascade impactor. Many particles display rounded profiles; some are fused together. (C and D) Spherical magnetite particles, Didcot power station, comprising fused magnetite particles (note the variable lattice orientations in C and the fused surface crystallites in D).
Fig. S11.
In a new window Download PPT
Fig. S11.
TEM image of magnetite nanoparticles captured from the exhaust plume of a diesel engine. Adapted from ref. 19.
Although PM mass has conventionally been used for setting of legislative airborne PM concentration limits, it is possible that ultrafine particle size and number are of greater significance in terms of mortality (26) and health impacts (e.g., ref. 27). Our magnetic measurements of roadside airborne PM [in Lancaster, United Kingdom (28)] indicate magnetite particle numbers equivalent to ∼2.01 × 108 m−3 of roadside air, for ∼50-nm-sized magnetite particles, for an ambient PM10 concentration of ∼40 Āµg⋅m−3 (compared, for example, with the annual mean PM10 for Mexico City of between ∼30 and 70 Āµg⋅m−3).
The abundant combustion-derived magnetite particles found in airborne PM can range widely in size, from less than 5 nm to more than 1 Āµm (15⇓–17, 19). Those particles of nanoscale dimensions, requiring analysis by transmission rather than scanning electron microscopy, have, until recently, received less attention than the larger, often more heterogenous spherules. Magnetite nanospheres up to ≾≾ 200 nm can have a direct entry route to the brain through the axons of the olfactory nerve, as suggested by experimental studies on carbon (29) and TiO2 nanoparticles (30), and the reported presence of NPs in the olfactory bulb of some Mexico City cases (14, 31⇓–33).
Although many of the highly magnetic brain samples come from the older Manchester cases (>65 y at death), especially those with severe to moderate AD, equivalent or higher magnetite concentrations are also displayed by young (<40 y at death) Mexico City residents, especially those exposed to high PM2.5 levels (annual mean ≳≳25 Āµg⋅m−3). Increased metals content and AD neuropathological hallmarks have been found in young human brains exposed to high airborne PM2.5 concentrations in Mexico City (14, 33). However, it was not previously known if the presence of metals in AD brains was due to transport to the brain of nanoparticles themselves or of their solubilized compounds. Our HRTEM results provide compelling evidence for the presence of externally sourced magnetite, and other metal-bearing nanoparticles in the frontal cortex of both the Mexico City and Manchester cases. It is notable that less than 5% of AD cases are directly inherited, indicating that nongenetic (environmental) factors, and/or gene/environment interactions, are likely playing a major role in initiating and/or promoting the disease. Jung et al. (34) found a 138% risk of increase of AD per increase of 4.34 Ī¼g⋅m−3 in PM2.5 over a 9-y follow-up period in 95,690 individuals in Taiwan. It is not yet understood which PM properties (e.g., size, number, mineralogy, and associated chemical species) contribute most to toxic effects (e.g., ref. 35). Our preliminary magnetic results regarding both PM exposure and AD are thus both intriguing and warrant more intensive study. Because of their combination of ultrafine size, specific brain toxicity, and ubiquity within airborne PM, pollution-derived magnetite nanoparticles might require consideration as a possible AD risk factor. In addition to occupational settings [including, for example, exposure to printer toner powders (36)], higher concentrations of magnetite pollution nanoparticles are likely to arise in the indoor environment from open fires (25) or poorly sealed stoves used for cooking and/or heating, and in the outdoor environment from vehicle (especially diesel) and/or industrial PM sources.
Previous Section
Next Section
Materials and Methods
Brain Samples. Fresh, frozen brain tissues were obtained from 38 individuals (Tables S1 and S2), 9 from the Manchester Brain Bank (ethical review and approval by the Manchester Brain Bank Management Committee and the Newcastle and North Tyneside I Regional Ethics Committee) and 29 from Mexico City, from forensic cases (fatal accidents) with no identifiable personal data, not meeting the regulatory definition of human subject research (University of Montana Institutional Review Board). A block (∼25 g) of tissue was cut from the frontal lobes; subsamples were cut using nonmagnetic [polytetrafluoroethylene (PTFE)] instruments. The Manchester samples were dissected into gray (nine samples) and white (eight samples) matter.
To preclude any contamination, or operator bias, samples were handled with nonmagnetic instruments in a laminar flow clean bench environment and measured blind to diagnostics, and sample holder remanences were removed. The tissue samples were freeze-dried and placed in polystyrene sample holders (10 cc) for magnetic measurements.
Magnetic Analyses. Magnetic measurements were made at the Centre for Environmental Magnetism and Paleomagnetism, Lancaster University, using superconducting quantum interference device magnetometry. Room-temperature isothermal remanent magnetizations (IRMs) (Fig. S2A) were measured with a GM400 Cryogenic Magnetometer (mean background noise level 5.9 ×10−11 A2; Cryogenic Consultants Ltd.); Low-temperature IRMs were measured (Fig. S2B) at temperatures between 293 and 77 K (±0.5 K) on a single-axis magnetic property measurement system XL magnetometer (Quantum Design). To identify magnetic grain sizes and/or magnetic interactions (37), anhysteretic remanence (ARM) was induced in a decaying (100 mT, peak) alternating magnetic field (af), with a small superimposed direct current (DC) field (0.08 mT), and subsequently af-demagnetized (Fig. S2C). Stepwise remanence acquisition was measured with incremental application of DC fields of 10, 20, 30, 50, 75, 100, and 300 mT and 1 T. The samples were cooled to 77 K and subjected to an applied DC field, 1 T, and their remanence was measured as they warmed to room temperature.
Tissue Sections.
Magnetically extracted particles. A subset of samples (six tissue samples, and one blank without any tissue) was subjected to a magnetic extraction procedure, designed to maximize removal of submicrometer ferrimagnets (20). All reagents were prepared from ultrapurity Milli-Q water and prefiltered (<0.1 Āµm PTFE membrane filter) to preclude any particulate contamination; all instruments and sample holders were nonmagnetic (PTFE and polystyrene, respectively).
Papain from papaya latex (twice-crystallized; Sigma) was solubilized in 50 mM sodium acetate (prefiltered and magnetically measured multiple times to demonstrably preclude magnetic contamination). The tissue samples were digested overnight in papain at 65 °C and at fixed pH 7.0 ± 0.02, in a strictly oxygen-free environment inside a particulate-clean laboratory. The resultant suspension was circulated continuously (2 to 3 d, with a peristaltic pump) past a magnetized probe, producing a high field gradient at its tip (maximum field ∼40 mT). The magnetically extracted particles were mounted on holey carbon films on carbon-coated copper grids for transmission electron microscopy (TEM).
HRTEM, EELS, and EDX. Electron microscopy was conducted on two instruments, a JEOL ARM200cF and an FEI Tecnai F20, operated at 200 kV. A Gatan Quantum spectrometer was used for EELS in scanning TEM (STEM) mode. Due to rapid carbon buildup under the electron beam, only point acquisition spectra were collected; each spectrum typically summed from several spectra from each nanoparticle and from multiple nanoparticles. This procedure also minimized the electron dose experienced by individual nanoparticles and ensured that their chemical reduction was avoided. Time-dependent observations did not reveal any obvious structural or spectroscopic changes to the nanoparticles within the acquisition time (but were observed under prolonged exposure), and we conclude that the EELS data presented are representative of the nanoparticles' as-formed chemistry. EELS data were processed in Python using Hyperspy package. To determine dominant lattice spacings, fast Fourier transforms (FFTs) of high-resolution micrographs were compared with a simulated diffraction pattern of face-centered cubic magnetite (space group Fd3¯mFd3¯m, no. 227, a = 8.3941 Ć
), and maghemite (space group P4332, no. 212, a = 8.3457 Ć
). Sample sensitivity under STEM imaging precluded elemental mapping by EDX.
Previous Section
Next Section
Acknowledgments
We appreciate the reviewers’ comments, which improved our manuscript. We thank Dr. Zabeada Aslam for her technical help, Dr. Mark Taylor (University of Lancaster) and Angelica Gonzalez-Maciel (Instituto Nacional de Pediatria, Mexico City) for assistance with tissue subsampling, and the University of Leeds Engineering and Physical Sciences Research Council-funded Nanoscience and Nanotechnology Facility for access to the HRTEM. We acknowledge the support of the Manchester Brain Bank by Alzheimer’s Research UK and Alzheimer’s Society through their funding of Brains for Dementia Research initiative, and service support costs from Medical Research Council.
Previous Section
Next Section
Footnotes
1To whom correspondence should be addressed. Email: b.maher@lancaster.ac.uk.
Author contributions: B.A.M. designed research; B.A.M., I.A.M.A., V.K., and D.A.M. performed research; P.G.F. and D.A. contributed new reagents/analytic tools; B.A.M., I.A.M.A., V.K., D.A.M., D.M.A.M., R.T.-J., and L.C.-G. analyzed data; B.A.M. wrote the paper; D.M.A.M. provided brain tissue samples and medical diagnosis data; R.T.-J. provided airborne PM data; and L.C.-G. provided brain tissue samples.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission. Y.R. is a Guest Editor invited by the Editorial Board.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1605941113/-/DCSupplemental.
Previous Section
References
↵ Kirschvink JL, Kobayashi-Kirschvink A, Woodford BJ (1992) Magnetite biomineralization in the human brain. Proc Natl Acad Sci USA 89(16):7683–7687.. Abstract/FREE Full Text
↵ Pankhurst Q, Hautot D, Khan N, Dobson J (2008) Increased levels of magnetic iron compounds in Alzheimer’s disease. J Alzheimers Dis 13(1):49–52.. MedlineWeb of ScienceGoogle Scholar
↵ Hautot D, Pankhurst QA, Khan N, Dobson J (2003) Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer’s disease brain tissue. Proc Biol Sci 270(Suppl 1):S62–S64.. Abstract/FREE Full Text
↵ Schultheiss-Grassi PP, Wessiken R, Dobson J (1999) TEM investigations of biogenic magnetite extracted from the human hippocampus. Biochim Biophys Acta 1426(1):212–216.. MedlineGoogle Scholar
↵ Quintana C, Cowley JM, Marhic C (2004) Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin. J Struct Biol 147(2):166–178.. CrossRefMedlineWeb of ScienceGoogle Scholar
↵ Dobson J (2002) Investigation of age-related variations in biogenic magnetite levels in the human hippocampus. Exp Brain Res 144(1):122–126.. CrossRefMedlineGoogle Scholar
↵ Teller S, Tahirbegi IB, Mir M, Samitier J, Soriano J (2015) Magnetite-Amyloid-Ī² deteriorates activity and functional organization in an in vitro model for Alzheimer's disease. Sci Rep 5:17261.. CrossRefMedlineGoogle Scholar
↵ Allsop D, Mayes J, Moore S, Masad A, Tabner BJ (2008) Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease. Biochem Soc Trans 36(Pt 6):1293–1298.. Abstract/FREE Full Text
↵ Tabner BJ, Mayes J, Allsop D (2010) Hypothesis: Soluble AĪ² oligomers in association with redox-active metal ions are the optimal generators of reactive oxygen species in Alzheimer’s disease. Int J Alzheimers Dis 2011:546380.. MedlineGoogle Scholar
↵ Castellani RJ, et al. (2007) Iron: The redox-active center of oxidative stress in Alzheimer disease. Neurochem Res 32(10):1640–1645.. CrossRefMedlineGoogle Scholar
↵ Collingwood J, Dobson J (2006) Mapping and characterization of iron compounds in Alzheimer's tissue. J Alzheimer's Dis 10(2-3):215–222.. MedlineWeb of ScienceGoogle Scholar
↵ Quintana C, et al. (2006) Study of the localization of iron, ferritin, and hemosiderin in Alzheimer’s disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 153(1):42–54.. CrossRefMedlineWeb of ScienceGoogle Scholar
↵ Plascencia-Villa G, et al. (2016) High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer’s disease. Sci Rep 6:24873.. CrossRefMedlineGoogle Scholar
↵ CalderĆ³n-GarcidueƱas L, et al. (2016) Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer’s disease. Environ Res 146:404–417.. Google Scholar
↵ Mitchell R, Maher BA (2009) Evaluation and application of biomagnetic monitoring of traffic-derived particulate pollution. Atmos Environ 43(13):2095–2103.. CrossRefWeb of ScienceGoogle Scholar
↵ Moreno T, et al. (2015) A new look at inhalable metalliferous airborne particles on rail subway platforms. Sci Total Environ 505:367–375.. CrossRefMedlineGoogle Scholar
↵ Chen Y, Shah N, Huggins FE, Huffman GP (2006) Microanalysis of ambient particles from Lexington, KY, by electron microscopy. Atmos Environ 40(4):651–663.. CrossRefGoogle Scholar
↵ Puffer JH, Russell EWB, Rampino MR (1980) Distribution and origin of magnetite spherules in air, waters, and sediments of the greater New York City Area and the North Atlantic Ocean. J Sediment Petrol 50(1):247–256.. Abstract/FREE Full Text
↵ Liati A, Pandurangi SS, Boulouchos K, Schreiber D, Dasilva YAR (2015) Metal nanoparticles in diesel exhaust derived by in-cylinder melting of detached engine fragments. Atmos Environ 101:34–40.. CrossRefGoogle Scholar
↵ Hounslow MW, Maher BA (1996) Quantitative extraction and analysis of carriers of magnetization in sediments. Geophys J Int 124(1):57–74.. Abstract/FREE Full Text
↵ KukutschovĆ” J, et al. (2011) On airborne nano/micro-sized wear particles released from low-metallic automotive brakes. Environ Pollut 159(4):998–1006.. CrossRefMedlineWeb of ScienceGoogle Scholar
↵ GĆ³mez B, GĆ³mez M, Sanchez JL, FernĆ”ndez R, Palacios MA (2001) Platinum and rhodium distribution in airborne particulate matter and road dust. Sci Total Environ 269(1-3):131–144.. CrossRefMedlineGoogle Scholar
↵ Abdul-Razzaq W, Gautam M (2001) Discovery of magnetite in the exhausted material from a diesel engine. Appl Phys Lett 78(14):2018–2019.. CrossRefGoogle Scholar
↵ Jordanova N, et al. (2006) Magnetism of cigarette ashes. J Magn Magn Mater 301(1):50–66.. CrossRefGoogle Scholar
↵ Mcclean RG, Kean WF (1993) Contributions of wood ash magnetism to archaeomagnetic properties of fire pits and hearths. Earth Planet Sci Lett 119(3):387–394.. CrossRefGoogle Scholar
↵ Brunekreef B, Forsberg B (2005) Epidemiological evidence of effects of coarse airborne particles on health. Eur Respir J 26(2):309–318.. Abstract/FREE Full Text
↵ Pieters N, et al. (2015) Blood pressure and same-day exposure to air pollution at school: Associations with nano-sized to coarse PM in children. Environ Health Perspect 123(7):737–742.. MedlineGoogle Scholar
↵ Halsall CJ, Maher BA, Karloukovski VV, Shah P, Watkins SJ (2008) A novel approach to investigating indoor/outdoor pollution links: Combined magnetic and PAH measurements. Atmos Environ 42(39):8902–8909.. CrossRefWeb of ScienceGoogle Scholar
↵ Oberdƶrster G, et al. (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16(6-7):437–445.. CrossRefMedlineWeb of ScienceGoogle Scholar
↵ Wang J, et al. (2008) Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology 254(1-2):82–90.. CrossRefMedlineWeb of ScienceGoogle Scholar
↵ CalderĆ³n-GarcidueƱas L, et al. (2003) DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol Pathol 31(5):524–538.. Abstract/FREE Full Text
↵ Block ML, CalderĆ³n-GarcidueƱas L (2009) Air pollution: Mechanisms of neuroinflammation and CNS disease. Trends Neurosci 32(9):506–516.. CrossRefMedlineWeb of ScienceGoogle Scholar
↵ CalderĆ³n-GarcidueƱas L, et al. (2013) The impact of environmental metals in young urbanites’ brains. Exp Toxicol Pathol 65(5):503–511.. CrossRefMedlineGoogle Scholar
↵ Jung C-R, Lin Y-T, Hwang B-F (2015) Ozone, particulate matter, and newly diagnosed Alzheimer’s disease: A population-based cohort study in Taiwan. J Alzheimers Dis 44(2):573–584.. MedlineGoogle Scholar
↵ Kƶnczƶl M, et al. (2011) Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: Role of ROS, JNK, and NF-ĪŗB. Chem Res Toxicol 24(9):1460–1475.. CrossRefMedlineGoogle Scholar
↵ Gminski R, et al. (2011) Genotoxic effects of three selected black toner powders and their dimethyl sulfoxide extracts in cultured human epithelial A549 lung cells in vitro. Environ Mol Mutagen 52(4):296–309.. CrossRefMedlineGoogle Scholar
↵ Maher BA (1988) Magnetic properties of some synthetic sub-micron magnetites. Geophys J Int 94(1):83–96.. Abstract/FREE Full Text
Thursday, September 7, 2017
Diethyl malonate, also known as DEM, is the diethyl ester of malonic acid. It occurs naturally in grapes and strawberries as a colourless liquid with an apple-like odour, and is used in perfumes. It is also used to synthesize other compounds such as barbiturates, artificial flavourings, vitamin B1, and vitamin B6.
Wednesday, September 6, 2017
Diethyl ether, or simply ether, is an organic compound in the ether class with the formula 2O. It is a colorless, highly volatile flammable liquid. It is commonly used as a solvent in laboratories and as a starting fluid for some engines. Wikipedia Formula: (C2H5)2O Density: 713 kg/m³ Boiling point: 34.6 °C Molar mass: 74.12 g/mol IUPAC ID: Ethoxyethane Melting point: -116.3 °C
Tuesday, September 5, 2017
Monday, September 4, 2017
Sunday, August 20, 2017
Monday, August 14, 2017
JULY 26, 2017, 7:00 AM Sweeping study shows sharply declining male fertility Meta-analysis finds that among men from North America, Europe and Australia, sperm concentration has declined more than 50% in less than 40 years. By ISRAEL21c Staff
A groundbreaking meta-analysis of data collected between 1973 and 2011 has found that sperm concentration has declined by more than half among men from Western countries, with no sign of a “leveling off” in recent years. The study appears today in Human Reproduction Update.
UNCOVER ISRAEL - Get the ISRAEL21c
Weekly Edition free by email Sign Up Now!
The research — the first systematic review and meta-analysis of trends in sperm count –was led by Dr. Hagai Levine, head of the Environmental Health Track at the Hebrew University-Hadassah Braun School of Public Health and Community Medicine, Jerusalem.
Levine worked with Dr. Shanna H Swan, professor in the Department of Environmental Medicine and Public Health at Icahn School of Medicine at Mount Sinai, New York, and other researchers from Brazil, Denmark, Israel, Spain and the United States.
Their findings strongly suggest a significant decline in male reproductive health that has serious implications beyond fertility and reproduction, as recent evidence shows that men with poor semen quality may have a higher risk of hospitalization and death from a variety of health conditions.
“Given the importance of sperm counts for male fertility and human health, this study is an urgent wake-up call for researchers and health authorities around the world to investigate the causes of the sharp ongoing drop in sperm count, with the goal of prevention,” said Levine.
Dr. Hagai Levine, the study’s lead author and Head of the Environmental Health Track at the Hebrew University-Hadassah Braun School of Public Health and Community Medicine. Photo courtesy of Hebrew University
Why are sperm counts declining?
When the researchers screened 7,500 studies and conducted a meta-regression analysis on 185 studies between 1973 and 2011, they found a 52.4 percent decline in sperm concentration, and a 59.3% decline in total sperm count among men from North America, Europe, Australia and New Zealand. The men were not selected based on their fertility status.
The study also indicates the rate of decline among Western men is not decreasing. The slope was steep and significant even when analysis was restricted to studies with sample collection between 1996 and 2011.
In contrast, no significant decline was seen in South America, Asia and Africa, although far fewer studies have been conducted in these places.
While declines in sperm count have been reported since 1992, the question has remained controversial because of limitations in past studies.
The current study used a broader scope and rigorous meta-regression methods, conservatively addressed the reliability of study estimates, and controlled for factors that might help explain the decline such as age, abstinence time, and selection of the study population.
The researchers did not examine causes of the observed decline. However, sperm count has been associated with environmental and lifestyle influences, including prenatal chemical exposure, adult pesticide exposure, smoking, stress and obesity.
“Decreasing sperm count has been of great concern since it was first reported 25 years ago. This definitive study shows, for the first time, that this decline is strong and continuing. The fact that the decline is seen in Western countries strongly suggests that chemicals in commerce are playing a causal role in this trend,” said Swan.
“We and others are also studying the association between poor semen quality or sperm function and fetal outcomes,” Levine tells ISRAEL21c.
Researchers from the Faculty of Health Sciences at Ben-Gurion University of the Negev in Beersheva also participated in the study along with scientists from the University of Copenhagen; Federal University of Parana, Curitiba, Brazil; and the University of Murcia School of Medicine and Biomedical Research Institute of Murcia, Spain.
Funding was provided by the Environment and Health Fund, Jerusalem; American Healthcare Professionals and Friends for Medicine in Israel; Israel Medical Association; Research Fund of Rigshospitalet; Brazilian National Council for Scientific and Technological Development; and the Mount Sinai Transdisciplinary Center on Early Environmental Exposures.
Read more on: Health, sperm count, fertility
Saturday, August 12, 2017
Friday, August 11, 2017
Thursday, August 10, 2017
Einstein's office in Princeton, New Jersey, photographed on the day of his death, April 18, 1955. pic.twitter.com/vmIu7IL4blš·
— History In Pictures (@LostlnHistory) August 10, 2017
Saturday, July 29, 2017
Here, we investigated the contribution of gut microbiota to chemoresistance in patients with colorectal cancer ; ARTICLESwitch to Standard View Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Highlights
•Specific gut microbes track with post-chemotherapy recurrence of colorectal cancer
•F. nucleatum orchestrates the Toll-like receptor, microRNAs, and autophagy network to control cancer chemoresistance
•Measuring and targeting F. nucleatum may be useful for patient prognosis and management
Summary
Gut microbiota are linked to chronic inflammation and carcinogenesis. Chemotherapy failure is the major cause of recurrence and poor prognosis in colorectal cancer patients. . We found that Fusobacterium (F.) nucleatum was abundant in colorectal cancer tissues in patients with recurrence post chemotherapy, and was associated with patient clinicopathological characterisitcs. Furthermore, our bioinformatic and functional studies demonstrated that F. nucleatum promoted colorectal cancer resistance to chemotherapy. Mechanistically, F. nucleatum targeted TLR4 and MYD88 innate immune signaling and specific microRNAs to activate the autophagy pathway and alter colorectal cancer chemotherapeutic response. Thus, F. nucleatum orchestrates a molecular network of the Toll-like receptor, microRNAs, and autophagy to clinically, biologically, and mechanistically control colorectal cancer chemoresistance. Measuring and targeting F. nucleatum and its associated pathway will yield valuable insight into clinical management and may ameliorate colorectal cancer patient outcomes.
Keywords:
Colorectal cancer, recurrence, chemoresistance, F.nucleatum, autophagy, Toll-like receptor, miRNA
To access this article, please choose from the options below
Log In
Login to existing account
Forgot password?
Register
Create a new account
Read-It-Now
Now available: purchase access to all research journal HTML articles for 6 or 36 hours. Click here to explore this opportunity.
Purchase Access to this Article
PDF Download and 24 Hours Online Access
Claim Access
If you are a current subscriber with Society Membership or an Account Number, claim your access now.
Subscribe to this Journal
Purchase a subscription to gain access to this and all other articles in this journal.
Tuesday, July 25, 2017
Science Communication & Visualisation - somersault18:24 shared Medical Videos's video. 37 mins · Great White - Cataract Eye Surgery Play -5:40 Additional Visual SettingsEnter Watch And ScrollEnter Fullscreen Unmute 1,842,406 Views Medical Videos July 18 at 7:03am · Great White - Cataract Eye Surgery
Tuesday, July 11, 2017
Subscribe to:
Posts (Atom)